{"gene":"RPE65","run_date":"2026-06-10T06:43:37","timeline":{"discoveries":[{"year":1998,"finding":"Rpe65-deficient mice lack rhodopsin (but retain opsin apoprotein), have abolished rod ERG responses, accumulate all-trans-retinyl esters in the RPE, and lack 11-cis-retinyl esters, establishing that RPE65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle.","method":"Rpe65 knockout mouse model; electroretinography; retinoid biochemical analysis by HPLC; immunohistochemistry","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — genetic knockout with multiple orthogonal biochemical and functional readouts; foundational paper replicated by subsequent studies","pmids":["9843205"],"is_preprint":false},{"year":2005,"finding":"Recombinant RPE65, when expressed in QBI-293A and COS-1 cells, catalyzes the conversion of all-trans-retinyl ester to 11-cis-retinol (isomerohydrolase activity) at a rate of ~2.9 pmol/min per mg; activity requires co-expression of lecithin retinol acyltransferase (LRAT) to provide substrate, establishing RPE65 as the visual cycle isomerohydrolase.","method":"Cell-based enzymatic assay (recombinant expression in QBI-293A and COS-1 cells); HPLC retinoid analysis; dose-response correlation with RPE65 expression levels","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro enzymatic reconstitution with substrate requirement defined; independently replicated in same year by Jin et al. (Cell)","pmids":["16116091"],"is_preprint":false},{"year":2005,"finding":"An unbiased cDNA expression screen identified Rpe65 as the retinoid isomerase converting all-trans-retinyl ester to 11-cis-retinol; Leber-associated missense mutations C330Y and Y368H abolished isomerase activity, confirming catalytic identity.","method":"Unbiased cDNA expression screen; catalytic activity assay in mammalian and insect cells; site-directed mutagenesis of disease-associated residues","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — unbiased functional screen plus mutagenesis validation; independent replication of isomerohydrolase identity","pmids":["16096063"],"is_preprint":false},{"year":1993,"finding":"RPE65 was molecularly cloned from bovine RPE; the 533-amino-acid protein lacks transmembrane segments, is RPE-specific by Northern blot, and the microsomal membrane-associated form has a higher apparent molecular mass than the soluble form, suggesting post-translational modification; cultured RPE cells contain RPE65 mRNA but no immunodetectable protein, indicating post-transcriptional regulation.","method":"cDNA library screening; RACE; heterologous expression in E. coli; Western blot; Northern blot; peptide microsequencing","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — original cloning paper with biochemical characterization; multiple orthogonal methods; foundational","pmids":["8340400"],"is_preprint":false},{"year":2001,"finding":"RPE65 exists in two forms in bovine RPE: a cytosolic form with mass close to calculated (~61 kDa) and a microsomal membrane-associated form with higher mass (~62 kDa), indicating the membrane-associated form carries post-translational modifications; recombinant human RPE65 expressed in Sf9 cells likewise shows membrane-associated and non-membrane forms with differing masses.","method":"Baculovirus/Sf9 expression; affinity chromatography purification; MALDI mass spectrometry; subcellular fractionation; Western blot; immunocytochemistry","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mass spectrometry plus fractionation in single lab; establishes post-translational modification on membrane form","pmids":["11381042"],"is_preprint":false},{"year":1997,"finding":"RPE65 lacks transmembrane domains yet associates with RPE microsomal membranes through hydrophobic/phospholipid interactions; RPE65 co-sediments with phosphatidylcholine and other phospholipid liposomes in a Ca2+-independent manner and binds PC-IAM matrix, demonstrating peripheral membrane association via phospholipid binding.","method":"Phospholipid liposome co-sedimentation assay; IAM chromatography; resonance energy transfer; spectrophotometric aggregation assay","journal":"Archives of biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical binding assays in single lab; establishes peripheral membrane association mechanism","pmids":["9328280"],"is_preprint":false},{"year":2010,"finding":"Hydrophobic interactions are the dominant forces promoting RPE65 association with native RPE microsomal membranes; phospholipid membrane structural integrity is critical for RPE65 isomerization activity (phospholipase A2 treatment inhibits 11-cis-retinol production in correlation with lipid hydrolysis kinetics); RPE65 operates in a multiprotein complex with retinol dehydrogenase 5 (RDH5) and retinal G protein-coupled receptor (RGR) in RPE microsomes.","method":"Membrane extraction and phase separation; phospholipase treatment with isomerase activity assay; co-immunoprecipitation from RPE microsomes","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods in single lab; establishes membrane dependence and protein complex","pmids":["20100834"],"is_preprint":false},{"year":2006,"finding":"Disease-associated RPE65 mutations R91W and Y368H both abolish isomerohydrolase activity in vitro and in vivo (subretinal injection into Rpe65-/- mice); these mutants show decreased protein stability (half-lives <2 h and <6 h vs. >10 h for WT) and shift from membrane to cytosolic fractions, indicating the mutations disrupt membrane association and reduce stability; palmitoylation is retained in both mutants.","method":"In vitro isomerohydrolase assay; subretinal injection rescue experiment in Rpe65-/- mice; protein stability/cycloheximide chase; subcellular fractionation; Western blot; palmitoylation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution assay combined with in vivo rescue and protein stability measurement; multiple orthogonal methods","pmids":["16754667"],"is_preprint":false},{"year":2005,"finding":"Adenovirus-mediated delivery of RPE65 to Rpe65-/- mice restores isomerohydrolase activity in eyecup homogenates to wild-type levels, restores normal retinoid profile (including 11-cis-retinal), and prevents early cone degeneration, confirming that RPE65 isomerohydrolase activity is required for cone photoreceptor survival.","method":"Subretinal adenovirus injection; in vitro isomerohydrolase activity assay; HPLC retinoid profiling; immunohistochemistry; cone counting on flatmounted retina; RT-PCR","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 1 / Strong — enzymatic activity restored in vivo with multiple biochemical and histological readouts confirming functional consequence","pmids":["16505056"],"is_preprint":false},{"year":2007,"finding":"RPE65 is essential for production of 11-cis-retinal for cone photoreceptors: ablation of RPE65 in Nrl-/- (cone-only) and Rho-/- mice eliminates 11-cis-retinal and causes a ~1000-fold drop in retinal sensitivity, demonstrating RPE65 is indispensable for cone as well as rod visual cycle function.","method":"Genetic crosses (Rpe65-/- × Nrl-/- and Rpe65-/- × Rho-/-); electroretinography; HPLC retinoid profiling; Western blot; immunohistochemistry","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 1 / Strong — double-knockout epistasis with multiple orthogonal measurements; clearly establishes RPE65 requirement for cone chromophore","pmids":["17251447"],"is_preprint":false},{"year":2002,"finding":"RPE65 protein is expressed in mammalian cone photoreceptors (mouse, rabbit, cow, Xenopus) but not in rods, as determined by immunohistochemistry on flatmounted and sectioned retinas; double-labeling with PNA confirmed cone identity, and RPE65 knockout confirmed antibody specificity.","method":"Immunohistochemistry on flatmounted and sectioned retinas; double-labeling with PNA; Western blot; RPE65 knockout control","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — immunohistochemistry with rigorous knockout control; single lab, two orthogonal detection methods","pmids":["11980880"],"is_preprint":false},{"year":1998,"finding":"RPE65 mRNA is expressed in salamander single cone cells (but not rods), as detected by RT-PCR on isolated cells, suggesting RPE65 contributes to the unique retinoid processing pathway in cones.","method":"RT-PCR on individually isolated photoreceptor cells; DNA sequencing confirmation","journal":"Biochimica et biophysica acta","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, RT-PCR only; functional consequence not directly tested","pmids":["9838153"],"is_preprint":false},{"year":2011,"finding":"RPE65 is present in human green/red cones but absent from blue cones; in the 661W cone cell line, RPE65 mediates ester hydrolysis for photopigment synthesis in vitro.","method":"Immunohistochemistry on human retinal sections; in vitro ester hydrolysis assay in 661W cone cell line","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — immunohistochemistry plus in vitro functional assay; single lab","pmids":["22171060"],"is_preprint":false},{"year":2007,"finding":"RPE65 retinoid isomerase activity is ~4-fold higher in central versus peripheral macaque RPE by direct enzymatic assay, and RPE65 concentrates in central retina by immunoblotting; early cone photoreceptor loss in RPE65-LCA patients indicates robust RPE65-based chromophore production is important for foveal cone survival.","method":"Retinoid isomerase activity assay on macaque RPE fractions; immunoblotting; immunocytochemistry; in vivo retinal imaging of human patients","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct enzymatic measurement in primate tissue plus human patient imaging; single lab","pmids":["17848510"],"is_preprint":false},{"year":2008,"finding":"The hypomorphic RPE65 mutation P25L reduces isomerohydrolase activity to 7.7% of wild-type in transfected 293F cells, and the L22P mutation to 13.5%; this residual activity correlates with a milder clinical phenotype (preserved cone function), establishing a dose-response relationship between RPE65 isomerase activity level and retinal functional outcome.","method":"Cell-based isomerase activity assay (293F cells); HPLC retinoid quantification; clinical ERG and psychophysics","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic assay with quantitative activity measurement correlated to clinical phenotype; single lab","pmids":["18599565"],"is_preprint":false},{"year":2008,"finding":"The novel RPE65 mutation G244V (near the catalytic center) causes protein instability in cultured cells and abolishes RPE65-dependent isomerase activity; homology modeling using the carotenoid oxygenase ACO structure localizes known inactivating mutations around the catalytic region.","method":"Cell-based isomerase assay; EGFP bicistronic expression + cell sorting + immunoblotting; homology modeling","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic assay plus structural modeling; single lab","pmids":["18722466"],"is_preprint":false},{"year":2014,"finding":"Three disease-associated RPE65 missense mutations (L22P, T101I, L408P) at non-active sites cause misfolding and aggregation via disulfide bonds; PSMD13 (26S proteasome non-ATPase regulatory subunit 13) interacts with and mediates rapid ubiquitination/proteasome-dependent degradation of misfolded (but not properly folded) mutant RPE65 proteins; low temperature, sodium 4-phenylbutyrate, and glycerol can rescue catalytic activity of non-active-site mutants but not active-site mutants.","method":"Co-immunoprecipitation; ubiquitination assay; proteasome inhibitor experiments; isomerase activity assay; low-temperature rescue assay; chemical chaperone treatment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (Co-IP, ubiquitination, proteasome inhibition, enzymatic assay, rescue); single lab with comprehensive mechanistic dissection","pmids":["24849605"],"is_preprint":false},{"year":2013,"finding":"FATP4 (fatty acid transport protein 4) is a negative regulator of RPE65 isomerase activity; lignoceroyl (C24:0)-CoA inhibits 11-cis-retinol synthesis whereas palmitoyl (C16:0)-CoA promotes it; FATP4-deficient RPE shows higher isomerase activity, faster 11-cis-retinaldehyde regeneration, and faster rod light sensitivity recovery; FATP4 competes with RPE65 for its substrate all-trans-retinyl ester.","method":"Unbiased bovine RPE cDNA expression screen; FATP4 knockout mice; isomerase activity assay; ERG recovery kinetics; substrate competition assay","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Strong — unbiased screen plus knockout model plus substrate competition assay; multiple orthogonal methods","pmids":["23407971"],"is_preprint":false},{"year":2019,"finding":"RPE65 undergoes S-palmitoylation (~25% of total protein) at residues C112 and C146; inhibition of palmitoylation abolishes membrane association; palmitoylation-deficient C112 mutants show impaired membrane association; LRAT dynamically regulates RPE65 palmitoylation level (decreased in the presence of all-trans-retinol, the LRAT substrate).","method":"Palmitoylation assay (acyl-RAC); 2-bromopalmitate and 2-fluoropalmitate inhibition; site-directed mutagenesis; membrane fractionation; LRAT co-expression experiments","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct palmitoylation assay with site-mapping mutagenesis, chemical inhibition, and functional (membrane association) readout; multiple orthogonal methods","pmids":["30914787"],"is_preprint":false},{"year":2018,"finding":"The dominant D477G RPE65 mutation generates an aggregation-prone surface; knock-in mice show ubiquitinated and reduced RPE65, retinyl ester accumulation, delayed rhodopsin regeneration kinetics, and diminished ERG responses; a cell line expressing D477G shows normal localization and isomerase activity, suggesting a toxic gain-of-function through abnormal complex formation rather than simple loss-of-function.","method":"D477G knock-in mouse model; immunoblot for ubiquitination; HPLC retinoid analysis; ERG; cell line isomerase activity assay; structural analysis of RPE65 chimera and crystal packing","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — knock-in mouse with multiple biochemical and functional readouts plus structural analysis; multiple orthogonal methods","pmids":["29659842"],"is_preprint":false},{"year":2016,"finding":"The D477G dominant mutation acts as a dominant-negative: heterozygous knock-in mice show slower kinetics of 11-cis-retinal regeneration after light exposure and delayed dark adaptation (lower A-wave recovery after photobleaching) compared with both wild-type and RPE65 heterozygous knockout mice, despite comparable steady-state 11-cis-retinal levels.","method":"D477G knock-in mouse; ERG photobleach-recovery kinetics; HPLC retinoid analysis","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo knock-in model with ERG and HPLC; single lab; complements Choi et al. 2018","pmids":["28041994"],"is_preprint":false},{"year":2019,"finding":"The human RPE65 c.1430A>G (D477G) mutation generates an ectopic splice site causing aberrant splicing of RPE65 mRNA, disrupting protein expression; this splicing defect was confirmed for the human mutant in an in vitro Exontrap assay; homozygous knock-in mice show light-stress-induced retinal degeneration.","method":"CRISPR/Cas9 knock-in mouse; Exontrap in vitro splicing assay; ERG; retinal histology; mRNA analysis","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro splicing assay plus knock-in mouse model; single lab; two orthogonal methods","pmids":["30628748"],"is_preprint":false},{"year":2010,"finding":"RPE65 cleavage occurs under oxidative stress: H2O2 exposure of RPE cells generates a novel 45 kDa truncated fragment (RPE45) via a caspase-mediated, ubiquitination-dependent mechanism; the same cleavage occurs in vivo upon light exposure in mice.","method":"Western blot; recombinant caspase cleavage assay; mass spectrometry; in vivo light-exposure experiment","journal":"International journal of biological macromolecules","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, limited mechanistic detail in abstract; caspase cleavage shown in vitro but ubiquitination-dependence claim not fully described","pmids":["20510285"],"is_preprint":false},{"year":2006,"finding":"The Rpe65 L450M/L450 sequence variant acts as a genetic modifier of retinal degeneration in a transgenic RP mouse model: mice with the Rpe65(450Met) variant retain more rhodopsin and show reduced retinal degeneration compared to mice with the Rpe65(450Leu) variant; phototransduction (not c-Fos) pathway mediates this light-driven degeneration.","method":"Transgenic mouse crosses with different Rpe65 variants; ERG; rhodopsin quantification; genetic epistasis (c-Fos KO and phototransduction mutant crosses)","journal":"The European journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in vivo with biochemical rhodopsin measurement; single lab","pmids":["16519667"],"is_preprint":false},{"year":2005,"finding":"In vivo, the initial rate of 11-cis-retinal synthesis is a Michaelis function of RPE65 quantity (Vmax ~18 pmol/min per eye, Km ~1.7 pmol); at sub-Km RPE65 levels, each RPE65 molecule supports ~10 molecules of 11-cis-retinal per minute regardless of the L450/M450 variant, establishing RPE65 as a quantitative rate-limiting factor for rhodopsin regeneration.","method":"Quantitative ELISA for RPE65 per eye; in vivo rhodopsin regeneration kinetics measured by ERG after bleach in five genotypes; Michaelis-Menten kinetic fitting","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative in vivo kinetic analysis across five genotypes in single lab; establishes catalytic rate limit","pmids":["16026160"],"is_preprint":false},{"year":2018,"finding":"A novel non-retinoid small molecule inhibitor CU239 selectively inhibits RPE65 isomerase activity (IC50 ~6 μM) via competition with its all-trans-retinyl ester substrate; systemic injection in mice delays chromophore regeneration and partially protects the retina from high-intensity light damage.","method":"In vitro isomerase activity assay; competitive inhibition kinetics; in vivo retinoid analysis (HPLC); ERG light-damage model in mice","journal":"Biochimica et biophysica acta. Molecular basis of disease","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro competitive inhibition plus in vivo validation; single lab; two orthogonal methods","pmids":["29684583"],"is_preprint":false},{"year":2005,"finding":"Nonsense mutation in exon 3 of Rpe65 in the rd12 mouse causes absence of RPE65 protein, no 11-cis-retinal, no rhodopsin, and retinyl ester accumulation in the RPE; the rd12 mutation maps to mouse chromosome 3 near the Rpe65 locus.","method":"Genetic linkage analysis; direct sequencing; immunohistochemistry; ERG; biochemical retinoid analysis","journal":"Molecular vision","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic mapping plus multiple biochemical confirmations; naturally occurring model corroborating human disease mechanism","pmids":["15765048"],"is_preprint":false},{"year":2009,"finding":"Eight RPE65 missense variants predicted to be disease-causing by an EPP algorithm all showed isomerase activity <6% of wild-type in a cell-culture assay; three variants predicted non-pathogenic showed activities of 68%, 127%, and 110% of wild-type; complete concordance between EPP prediction and functional assay established that most RPE65 disease mutations cause loss of isomerase function.","method":"Cell-based isomerase activity assay; site-directed mutagenesis of 11 RPE65 variants; EPP algorithm","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — systematic in vitro functional testing of 11 variants; single lab; comprehensive variant series","pmids":["19431183"],"is_preprint":false},{"year":2014,"finding":"The rd12 allele does not complement the Rpe65 knockout allele (complementation test), confirming the rd12 lesion is in Rpe65; the rd12 mutant mRNA is correctly spliced and exported to cytoplasm but is enriched on ribosome-free mRNPs rather than actively translating polyribosomes, indicating translational suppression as the mechanism of absent protein; the rd12 allele exerts a semidominant negative effect on visual function.","method":"Complementation cross; sucrose gradient polysome fractionation; RNA FISH; qRT-PCR; ERG; optokinetic tracking; immunoblot","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — polysome fractionation plus complementation test plus multiple functional readouts; single lab; multiple orthogonal methods","pmids":["24644049"],"is_preprint":false},{"year":2005,"finding":"In zebrafish (cone-dominated retina), RPE65 knockdown reduces 11-cis-retinal levels and alters rod outer segment morphology, but cone vision remains functional; all-trans retinylamine (rod visual cycle inhibitor) does not have additive effects in RPE65-deficient larvae, providing in vivo evidence for an RPE65-independent pathway for cone 11-cis-retinal regeneration.","method":"Morpholino-mediated gene knockdown in zebrafish; behavioral vision testing; HPLC retinoid profiling; retinylamine pharmacological inhibition","journal":"The European journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockdown plus pharmacological epistasis in vivo; single lab; two orthogonal approaches","pmids":["17868371"],"is_preprint":false},{"year":1998,"finding":"A 4-nucleotide (AAGA) deletion in canine RPE65 (nucleotides 487-490) causing a frameshift and premature stop codon is homozygous in RPE65-mutant Briard dogs with congenital stationary night blindness and retinal dystrophy; the mutation causes retinal dysfunction and RPE lipid vacuole accumulation, demonstrating that RPE65 loss of function disrupts the visual cycle and retinal architecture.","method":"RT-PCR and cDNA cloning; direct sequencing; ERG; fundus and morphological examination; haplotype analysis","journal":"Molecular vision","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and biochemical characterization of naturally occurring animal model; corroborates knockout mouse mechanism","pmids":["9808841"],"is_preprint":false},{"year":2018,"finding":"Cone-expressed RPE65 in mouse cones does not detectably contribute to cone function or morphology in transgenic mice expressing human RPE65 specifically in cones on an RPE65-deficient background; only a slight delay in dark adaptation was observed, possibly due to retinoid buffering.","method":"Transgenic mice (cone-specific human RPE65 expression in RPE65-deficient background); ERG dark adaptation; single-cell electrophysiology; morphological analysis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function transgenic model with multiple functional readouts; single lab; negative result for cone-specific RPE65 function in mouse","pmids":["30242264"],"is_preprint":false}],"current_model":"RPE65 is an isomerohydrolase enzyme in the retinal pigment epithelium that catalyzes the conversion of all-trans-retinyl esters (provided via LRAT activity) to 11-cis-retinol, the rate-limiting step in visual chromophore regeneration; it associates with ER membranes through hydrophobic and S-palmitoylation (at C112/C146, ~25% of protein) interactions, operates in a multiprotein complex with RDH5 and RGR, is negatively regulated by FATP4/ELOVL1 via competition for substrate, is targeted for proteasomal degradation when misfolded (via PSMD13), and is essential for both rod and cone photoreceptor function; most disease-causing missense mutations abolish isomerase activity or destabilize the protein, while the dominant D477G mutation delays chromophore regeneration through a toxic gain-of-function or dominant-negative mechanism involving abnormal complex formation."},"narrative":{"mechanistic_narrative":"RPE65 is the retinal pigment epithelium-specific retinoid isomerohydrolase that performs the rate-limiting step of the visual cycle, converting all-trans-retinyl esters into 11-cis-retinol for regeneration of the visual chromophore [PMID:16116091, PMID:16096063, PMID:16026160]. Genetic ablation in mice abolishes 11-cis-retinoid production and rhodopsin, accumulates all-trans-retinyl esters in the RPE, and eliminates rod ERG responses, establishing RPE65 as indispensable for chromophore supply [PMID:9843205]; epistasis in cone-only and rod-null backgrounds shows it is equally required for cone vision, with foveal cones being especially dependent on robust RPE65 activity [PMID:17251447, PMID:17848510]. Catalysis requires LRAT to generate the all-trans-retinyl ester substrate, and RPE65 functions within an RPE microsomal multiprotein complex together with RDH5 and RGR [PMID:16116091, PMID:20100834]. Although it lacks transmembrane segments, RPE65 associates peripherally with ER/microsomal membranes through hydrophobic and phospholipid interactions and through S-palmitoylation at C112 and C146, with membrane integrity being essential for isomerase activity [PMID:9328280, PMID:20100834, PMID:30914787]. RPE65 activity is quantitatively rate-limiting and tunable: it is negatively regulated by FATP4 through competition for the retinyl ester substrate, with very-long-chain acyl-CoAs inhibiting and palmitoyl-CoA promoting activity [PMID:23407971, PMID:16026160]. RPE65 loss-of-function and instability cause inherited retinal dystrophy: most disease-associated missense mutations abolish isomerase activity or destabilize the protein, and non-active-site misfolding mutants are cleared by PSMD13-mediated ubiquitin-proteasome degradation, whereas the dominant D477G mutation delays chromophore regeneration through a toxic/dominant-negative mechanism involving abnormal complex formation [PMID:16754667, PMID:24849605, PMID:29659842, PMID:19431183].","teleology":[{"year":1993,"claim":"Established RPE65 as an RPE-specific protein and raised the question of how a soluble-looking protein associates with membranes, setting up the membrane-association and post-translational regulation problems.","evidence":"cDNA cloning from bovine RPE, Northern/Western blot, peptide microsequencing","pmids":["8340400"],"confidence":"High","gaps":["Did not assign a catalytic function","Nature of the higher-mass membrane modification undefined","Mechanism of post-transcriptional regulation in cultured RPE not identified"]},{"year":1998,"claim":"Defined RPE65's physiological role by showing its loss blocks 11-cis-retinoid production and rhodopsin formation, identifying it as a required node in the retinal visual cycle.","evidence":"Rpe65 knockout mice with ERG, HPLC retinoid analysis, immunohistochemistry; corroborated by canine frameshift model","pmids":["9843205","9808841"],"confidence":"High","gaps":["Did not establish the biochemical reaction RPE65 catalyzes","Direct enzyme activity not demonstrated","Role in cones not yet tested"]},{"year":1997,"claim":"Showed RPE65 is a peripheral membrane protein associating with microsomes via phospholipid/hydrophobic interactions, answering how a protein lacking transmembrane domains localizes to membranes.","evidence":"Liposome co-sedimentation, IAM chromatography, resonance energy transfer","pmids":["9328280"],"confidence":"Medium","gaps":["Specific residues/modifications mediating association not mapped","Single-lab biochemistry","Functional consequence of membrane association untested here"]},{"year":2005,"claim":"Resolved RPE65's molecular activity by directly demonstrating isomerohydrolase catalysis of all-trans-retinyl ester to 11-cis-retinol, and showed it depends on LRAT for substrate and is quantitatively rate-limiting in vivo.","evidence":"Recombinant expression enzymatic assays in mammalian/insect cells with HPLC, unbiased cDNA screen, mutagenesis of LCA residues, in vivo Michaelis-Menten kinetics; rd12 nonsense model","pmids":["16116091","16096063","16026160","15765048"],"confidence":"High","gaps":["Catalytic mechanism/cofactor requirements not fully defined","Structure not solved","Relationship to membrane association mechanistically incomplete"]},{"year":2007,"claim":"Demonstrated RPE65 is required for the cone as well as rod visual cycle, addressing whether cones use an RPE65-independent chromophore source.","evidence":"Rpe65 ablation in Nrl-/- and Rho-/- mice with ERG and HPLC; gene-delivery rescue preventing cone degeneration; cone expression and central RPE enrichment data","pmids":["17251447","16505056","11980880","22171060","17848510"],"confidence":"High","gaps":["Whether cone-intrinsic RPE65 contributes vs RPE-derived chromophore not resolved","Cone-specific alternative pathway in some species (zebrafish) unexplained","Quantitative cone vs rod chromophore demand undefined"]},{"year":2018,"claim":"Tested whether RPE65 expressed within cones is functionally relevant, refining where chromophore-regenerating activity matters.","evidence":"Cone-specific human RPE65 transgenic mice on RPE65-deficient background; ERG, single-cell electrophysiology; zebrafish knockdown with retinylamine epistasis","pmids":["30242264","17868371"],"confidence":"Medium","gaps":["Negative result in mouse may not generalize across species","Identity of the RPE65-independent cone pathway unknown","Buffering vs catalytic role of cone RPE65 unresolved"]},{"year":2006,"claim":"Connected disease mutations to mechanism by showing inactivating mutations abolish isomerase activity and destabilize protein while shifting it off membranes, defining loss-of-function as the dominant disease route.","evidence":"In vitro isomerase assays, subretinal rescue in Rpe65-/- mice, cycloheximide-chase stability, fractionation; systematic functional testing of variant series; homology modeling","pmids":["16754667","19431183","18599565","18722466"],"confidence":"High","gaps":["Per-residue catalytic contributions not fully mapped without a crystal structure","Relationship between stability loss and membrane displacement mechanistically incomplete","Residual-activity thresholds for phenotype only correlative"]},{"year":2014,"claim":"Identified the quality-control pathway disposing of misfolded RPE65, showing PSMD13 mediates ubiquitin-proteasome degradation of misfolding mutants and that chemical chaperones rescue non-active-site but not active-site mutants.","evidence":"Co-IP, ubiquitination assay, proteasome inhibition, isomerase activity, low-temperature and 4-PBA/glycerol rescue; rd12 translational-suppression analysis","pmids":["24849605","24644049"],"confidence":"High","gaps":["Whether PSMD13 acts via canonical 26S targeting or a dedicated recognition step unclear","In vivo relevance of this pathway not tested","E3 ligase for RPE65 not identified"]},{"year":2013,"claim":"Revealed metabolic regulation of RPE65 by showing FATP4 negatively modulates isomerase activity through substrate competition and acyl-CoA chain-length effects, linking chromophore regeneration speed to lipid metabolism.","evidence":"Unbiased bovine RPE cDNA screen, FATP4 knockout mice, isomerase and ERG recovery kinetics, substrate competition assays","pmids":["23407971"],"confidence":"High","gaps":["Physiological conditions that engage FATP4 regulation undefined","Whether ELOVL1 or other lipid enzymes participate not tested here","Stoichiometry of competition at the membrane unknown"]},{"year":2019,"claim":"Defined S-palmitoylation as a regulated determinant of RPE65 membrane association, mapping modified cysteines and linking palmitoylation dynamics to LRAT substrate availability.","evidence":"Acyl-RAC palmitoylation assay, palmitoylation inhibitors, C112/C146 mutagenesis, membrane fractionation, LRAT co-expression","pmids":["30914787"],"confidence":"High","gaps":["Palmitoyltransferase responsible not identified","Functional consequence on catalytic rate vs localization not fully separated","In vivo significance of dynamic palmitoylation untested"]},{"year":2019,"claim":"Mechanistically dissected the dominant D477G mutation, showing it acts through a toxic gain-of-function/dominant-negative route (aggregation-prone surface, abnormal complex formation, delayed regeneration) plus a human splicing defect, distinguishing it from recessive loss-of-function.","evidence":"D477G knock-in mice with HPLC/ERG/ubiquitination, cell-line activity assay, structural analysis, heterozygote dominant-negative kinetics, Exontrap splicing assay","pmids":["29659842","28041994","30628748"],"confidence":"High","gaps":["Relative contributions of splicing defect vs protein-level toxicity in humans unresolved","Composition of the abnormal complex not defined","Whether the same mechanism operates in human RPE not directly shown"]},{"year":2018,"claim":"Established pharmacological tractability of the substrate-binding site by developing a competitive non-retinoid inhibitor that slows chromophore regeneration and protects against light damage.","evidence":"In vitro competitive inhibition kinetics (CU239), in vivo HPLC and ERG light-damage model in mice","pmids":["29684583"],"confidence":"Medium","gaps":["Binding mode not structurally resolved","Therapeutic window and selectivity in humans untested","Long-term consequences of chronic inhibition unknown"]},{"year":null,"claim":"How RPE65, LRAT, RDH5, RGR and lipid regulators are spatially organized into a functional membrane-bound visual-cycle machine, and the high-resolution catalytic mechanism of isomerization, remain incompletely defined.","evidence":"","pmids":[],"confidence":"Low","gaps":["No experimentally determined high-resolution structure of human RPE65 in the timeline","Architecture and stoichiometry of the RDH5/RGR complex undefined","Identity of palmitoyltransferase and ubiquitin ligase acting on RPE65 unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016853","term_label":"isomerase activity","supporting_discovery_ids":[1,2,8,14,27]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[1,12]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[5,6]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[4,5,6]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[4,7]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[5,18]}],"pathway":[{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[0,8,9]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[1,17]}],"complexes":["RPE65-RDH5-RGR RPE microsomal isomerization complex"],"partners":["LRAT","RDH5","RGR","FATP4","PSMD13"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q16518","full_name":"Retinoid isomerohydrolase","aliases":["All-trans-retinyl-palmitate hydrolase","Lutein isomerase","Meso-zeaxanthin isomerase","Retinal pigment epithelium-specific 65 kDa protein","Retinol isomerase"],"length_aa":533,"mass_kda":60.9,"function":"Critical isomerohydrolase in the retinoid cycle involved in regeneration of 11-cis-retinal, the chromophore of rod and cone opsins. Catalyzes the cleavage and isomerization of all-trans-retinyl fatty acid esters to 11-cis-retinol which is further oxidized by 11-cis retinol dehydrogenase to 11-cis-retinal for use as visual chromophore (PubMed:16116091). Essential for the production of 11-cis retinal for both rod and cone photoreceptors (PubMed:17848510). Also capable of catalyzing the isomerization of lutein to meso-zeaxanthin an eye-specific carotenoid (PubMed:28874556). The soluble form binds vitamin A (all-trans-retinol), making it available for LRAT processing to all-trans-retinyl ester. The membrane form, palmitoylated by LRAT, binds all-trans-retinyl esters, making them available for IMH (isomerohydrolase) processing to all-cis-retinol. The soluble form is regenerated by transferring its palmitoyl groups onto 11-cis-retinol, a reaction catalyzed by LRAT (By similarity)","subcellular_location":"Cytoplasm; Cell membrane; Microsome membrane","url":"https://www.uniprot.org/uniprotkb/Q16518/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RPE65","classification":"Not Classified","n_dependent_lines":103,"n_total_lines":1208,"dependency_fraction":0.08526490066225166},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RPE65","total_profiled":1310},"omim":[{"mim_id":"620124","title":"ZINC FINGER PROTEIN 492; ZNF492","url":"https://www.omim.org/entry/620124"},{"mim_id":"618697","title":"RETINITIS PIGMENTOSA 87 WITH CHOROIDAL INVOLVEMENT; RP87","url":"https://www.omim.org/entry/618697"},{"mim_id":"613862","title":"RETINITIS PIGMENTOSA 38; RP38","url":"https://www.omim.org/entry/613862"},{"mim_id":"613843","title":"LEBER CONGENITAL AMAUROSIS 15; LCA15","url":"https://www.omim.org/entry/613843"},{"mim_id":"613794","title":"RETINITIS PIGMENTOSA 20; RP20","url":"https://www.omim.org/entry/613794"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":5.2},{"tissue":"choroid plexus","ntpm":3.5},{"tissue":"retina","ntpm":7.8},{"tissue":"seminal vesicle","ntpm":4.2}],"url":"https://www.proteinatlas.org/search/RPE65"},"hgnc":{"alias_symbol":["LCA2","rd12","BCO3"],"prev_symbol":["RP20"]},"alphafold":{"accession":"Q16518","domains":[{"cath_id":"2.130.10.10","chopping":"10-531","consensus_level":"medium","plddt":95.5093,"start":10,"end":531}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16518","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q16518-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q16518-F1-predicted_aligned_error_v6.png","plddt_mean":95.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RPE65","jax_strain_url":"https://www.jax.org/strain/search?query=RPE65"},"sequence":{"accession":"Q16518","fasta_url":"https://rest.uniprot.org/uniprotkb/Q16518.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q16518/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16518"}},"corpus_meta":[{"pmid":"28712537","id":"PMC_28712537","title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.","date":"2017","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28712537","citation_count":1517,"is_preprint":false},{"pmid":"9843205","id":"PMC_9843205","title":"Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle.","date":"1998","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9843205","citation_count":814,"is_preprint":false},{"pmid":"21911650","id":"PMC_21911650","title":"Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years.","date":"2011","source":"Archives of ophthalmology (Chicago, Ill. : 1960)","url":"https://pubmed.ncbi.nlm.nih.gov/21911650","citation_count":526,"is_preprint":false},{"pmid":"16116091","id":"PMC_16116091","title":"RPE65 is the isomerohydrolase in the retinoid visual cycle.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16116091","citation_count":455,"is_preprint":false},{"pmid":"9501220","id":"PMC_9501220","title":"Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9501220","citation_count":386,"is_preprint":false},{"pmid":"16096063","id":"PMC_16096063","title":"Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16096063","citation_count":369,"is_preprint":false},{"pmid":"31443789","id":"PMC_31443789","title":"Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials.","date":"2019","source":"Ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/31443789","citation_count":322,"is_preprint":false},{"pmid":"8340400","id":"PMC_8340400","title":"Molecular cloning and expression of RPE65, a novel retinal pigment epithelium-specific microsomal protein that is post-transcriptionally regulated in vitro.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8340400","citation_count":265,"is_preprint":false},{"pmid":"19583479","id":"PMC_19583479","title":"Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year.","date":"2009","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/19583479","citation_count":263,"is_preprint":false},{"pmid":"11095629","id":"PMC_11095629","title":"Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration.","date":"2000","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/11095629","citation_count":226,"is_preprint":false},{"pmid":"20399883","id":"PMC_20399883","title":"Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy.","date":"2010","source":"Progress in retinal and eye research","url":"https://pubmed.ncbi.nlm.nih.gov/20399883","citation_count":207,"is_preprint":false},{"pmid":"12657607","id":"PMC_12657607","title":"Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog.","date":"2003","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/12657607","citation_count":200,"is_preprint":false},{"pmid":"15765048","id":"PMC_15765048","title":"Retinal degeneration 12 (rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis (LCA).","date":"2005","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/15765048","citation_count":193,"is_preprint":false},{"pmid":"16223604","id":"PMC_16223604","title":"Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis.","date":"2005","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/16223604","citation_count":171,"is_preprint":false},{"pmid":"9808841","id":"PMC_9808841","title":"Congenital stationary night blindness in the dog: common mutation in the RPE65 gene indicates founder effect.","date":"1998","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/9808841","citation_count":154,"is_preprint":false},{"pmid":"33278565","id":"PMC_33278565","title":"Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy.","date":"2020","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33278565","citation_count":139,"is_preprint":false},{"pmid":"17848510","id":"PMC_17848510","title":"Human cone photoreceptor dependence on RPE65 isomerase.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17848510","citation_count":138,"is_preprint":false},{"pmid":"21654732","id":"PMC_21654732","title":"A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement.","date":"2011","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/21654732","citation_count":132,"is_preprint":false},{"pmid":"19373675","id":"PMC_19373675","title":"RPE65: role in the visual cycle, human retinal disease, and gene therapy.","date":"2009","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19373675","citation_count":126,"is_preprint":false},{"pmid":"25635059","id":"PMC_25635059","title":"The Status of RPE65 Gene Therapy Trials: Safety and Efficacy.","date":"2015","source":"Cold Spring Harbor perspectives in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25635059","citation_count":123,"is_preprint":false},{"pmid":"29033008","id":"PMC_29033008","title":"Safety and Long-Term Efficacy of AAV4 Gene Therapy in Patients with RPE65 Leber Congenital Amaurosis.","date":"2017","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29033008","citation_count":110,"is_preprint":false},{"pmid":"17032058","id":"PMC_17032058","title":"Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis.","date":"2006","source":"PLoS medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17032058","citation_count":102,"is_preprint":false},{"pmid":"11980880","id":"PMC_11980880","title":"Identification of the RPE65 protein in mammalian cone photoreceptors.","date":"2002","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/11980880","citation_count":98,"is_preprint":false},{"pmid":"17594175","id":"PMC_17594175","title":"Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation.","date":"2007","source":"PLoS medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17594175","citation_count":97,"is_preprint":false},{"pmid":"30335549","id":"PMC_30335549","title":"Gene therapy for RPE65-related retinal disease.","date":"2018","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30335549","citation_count":92,"is_preprint":false},{"pmid":"12692160","id":"PMC_12692160","title":"In vivo gene therapy in young and adult RPE65-/- dogs produces long-term visual improvement.","date":"2003","source":"The Journal of heredity","url":"https://pubmed.ncbi.nlm.nih.gov/12692160","citation_count":92,"is_preprint":false},{"pmid":"31692906","id":"PMC_31692906","title":"CRISPR-Cas9-mediated therapeutic editing of Rpe65 ameliorates the disease phenotypes in a mouse model of Leber congenital amaurosis.","date":"2019","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/31692906","citation_count":89,"is_preprint":false},{"pmid":"18599565","id":"PMC_18599565","title":"A comprehensive clinical and biochemical functional study of a novel RPE65 hypomorphic mutation.","date":"2008","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/18599565","citation_count":75,"is_preprint":false},{"pmid":"34607013","id":"PMC_34607013","title":"Retinal pigment epithelium 65 kDa protein (RPE65): An update.","date":"2021","source":"Progress in retinal and eye research","url":"https://pubmed.ncbi.nlm.nih.gov/34607013","citation_count":74,"is_preprint":false},{"pmid":"16505056","id":"PMC_16505056","title":"RPE65 gene delivery restores isomerohydrolase activity and prevents early cone loss in Rpe65-/- mice.","date":"2006","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/16505056","citation_count":73,"is_preprint":false},{"pmid":"31604676","id":"PMC_31604676","title":"Long-Term Structural Outcomes of Late-Stage RPE65 Gene Therapy.","date":"2019","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31604676","citation_count":63,"is_preprint":false},{"pmid":"20237510","id":"PMC_20237510","title":"Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency.","date":"2010","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/20237510","citation_count":62,"is_preprint":false},{"pmid":"17197551","id":"PMC_17197551","title":"RDH12 and RPE65, visual cycle genes causing leber congenital amaurosis, differ in disease expression.","date":"2007","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/17197551","citation_count":61,"is_preprint":false},{"pmid":"20703309","id":"PMC_20703309","title":"Gene therapy in the second eye of RPE65-deficient dogs improves retinal function.","date":"2010","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/20703309","citation_count":61,"is_preprint":false},{"pmid":"17251447","id":"PMC_17251447","title":"RPE65 is essential for the function of cone photoreceptors in NRL-deficient mice.","date":"2007","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/17251447","citation_count":60,"is_preprint":false},{"pmid":"20100834","id":"PMC_20100834","title":"Importance of membrane structural integrity for RPE65 retinoid isomerization activity.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20100834","citation_count":59,"is_preprint":false},{"pmid":"16026160","id":"PMC_16026160","title":"Mole quantity of RPE65 and its productivity in the generation of 11-cis-retinal from retinyl esters in the living mouse eye.","date":"2005","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16026160","citation_count":59,"is_preprint":false},{"pmid":"11381042","id":"PMC_11381042","title":"Expression, purification, and MALDI analysis of RPE65.","date":"2001","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/11381042","citation_count":58,"is_preprint":false},{"pmid":"21169527","id":"PMC_21169527","title":"Gene therapy rescues cone structure and function in the 3-month-old rd12 mouse: a model for midcourse RPE65 leber congenital amaurosis.","date":"2011","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/21169527","citation_count":57,"is_preprint":false},{"pmid":"32059734","id":"PMC_32059734","title":"The effect of human gene therapy for RPE65-associated Leber's congenital amaurosis on visual function: a systematic review and meta-analysis.","date":"2020","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/32059734","citation_count":55,"is_preprint":false},{"pmid":"22951453","id":"PMC_22951453","title":"RPE65 gene therapy slows cone loss in Rpe65-deficient dogs.","date":"2012","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/22951453","citation_count":54,"is_preprint":false},{"pmid":"20304090","id":"PMC_20304090","title":"Membrane-binding and enzymatic properties of RPE65.","date":"2010","source":"Progress in retinal and eye research","url":"https://pubmed.ncbi.nlm.nih.gov/20304090","citation_count":53,"is_preprint":false},{"pmid":"16519667","id":"PMC_16519667","title":"Rpe65 as a modifier gene for inherited retinal degeneration.","date":"2006","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16519667","citation_count":51,"is_preprint":false},{"pmid":"29869534","id":"PMC_29869534","title":"Results at 5 Years After Gene Therapy for RPE65-Deficient Retinal Dystrophy.","date":"2018","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29869534","citation_count":48,"is_preprint":false},{"pmid":"17868371","id":"PMC_17868371","title":"Evidence for RPE65-independent vision in the cone-dominated zebrafish retina.","date":"2007","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17868371","citation_count":46,"is_preprint":false},{"pmid":"11786058","id":"PMC_11786058","title":"Clinical course and visual function in a family with mutations in the RPE65 gene.","date":"2002","source":"Archives of ophthalmology (Chicago, Ill. : 1960)","url":"https://pubmed.ncbi.nlm.nih.gov/11786058","citation_count":44,"is_preprint":false},{"pmid":"12356839","id":"PMC_12356839","title":"Retinal degeneration and RPE transplantation in Rpe65(-/-) mice.","date":"2002","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/12356839","citation_count":44,"is_preprint":false},{"pmid":"32149547","id":"PMC_32149547","title":"Voretigene neparvovec-rzyl for treatment of RPE65-mediated inherited retinal diseases: a model for ocular gene therapy development.","date":"2020","source":"Expert opinion on biological therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32149547","citation_count":43,"is_preprint":false},{"pmid":"9501877","id":"PMC_9501877","title":"Promoter analysis of RPE65, the gene encoding a 61-kDa retinal pigment epithelium-specific protein.","date":"1998","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/9501877","citation_count":42,"is_preprint":false},{"pmid":"19431183","id":"PMC_19431183","title":"Predicting the pathogenicity of RPE65 mutations.","date":"2009","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/19431183","citation_count":42,"is_preprint":false},{"pmid":"16485283","id":"PMC_16485283","title":"Visual cycle protein RPE65 persists in new retinal cells during retinal regeneration of adult newt.","date":"2006","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16485283","citation_count":42,"is_preprint":false},{"pmid":"24849605","id":"PMC_24849605","title":"Rescue of enzymatic function for disease-associated RPE65 proteins containing various missense mutations in non-active sites.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24849605","citation_count":41,"is_preprint":false},{"pmid":"19407008","id":"PMC_19407008","title":"Evaluation of 9-cis-retinyl acetate therapy in Rpe65-/- mice.","date":"2009","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/19407008","citation_count":41,"is_preprint":false},{"pmid":"12124981","id":"PMC_12124981","title":"Prenatal human ocular degeneration occurs in Leber's congenital amaurosis (LCA2).","date":"2002","source":"The journal of gene medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12124981","citation_count":40,"is_preprint":false},{"pmid":"9838153","id":"PMC_9838153","title":"Cloning and localization of RPE65 mRNA in salamander cone photoreceptor cells1.","date":"1998","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9838153","citation_count":40,"is_preprint":false},{"pmid":"22171060","id":"PMC_22171060","title":"RPE65 is present in human green/red cones and promotes photopigment regeneration in an in vitro cone cell model.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22171060","citation_count":39,"is_preprint":false},{"pmid":"37704110","id":"PMC_37704110","title":"Single Center Experience with Voretigene Neparvovec Gene Augmentation Therapy in RPE65 Mutation-Associated Inherited Retinal Degeneration in a Clinical Setting.","date":"2023","source":"Ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/37704110","citation_count":38,"is_preprint":false},{"pmid":"35098484","id":"PMC_35098484","title":"Epidemiology of Mutations in the 65-kDa Retinal Pigment Epithelium (RPE65) Gene-Mediated Inherited Retinal Dystrophies: A Systematic Literature Review.","date":"2022","source":"Advances in therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35098484","citation_count":38,"is_preprint":false},{"pmid":"9328280","id":"PMC_9328280","title":"RPE65, the major retinal pigment epithelium microsomal membrane protein, associates with phospholipid liposomes.","date":"1997","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/9328280","citation_count":38,"is_preprint":false},{"pmid":"24035979","id":"PMC_24035979","title":"Persistence of non-viral vector mediated RPE65 expression: case for viability as a gene transfer therapy for RPE-based diseases.","date":"2013","source":"Journal of controlled release : official journal of the Controlled Release Society","url":"https://pubmed.ncbi.nlm.nih.gov/24035979","citation_count":37,"is_preprint":false},{"pmid":"29659842","id":"PMC_29659842","title":"Insights into the pathogenesis of dominant retinitis pigmentosa associated with a D477G mutation in RPE65.","date":"2018","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29659842","citation_count":35,"is_preprint":false},{"pmid":"25537204","id":"PMC_25537204","title":"Pseudo-fovea formation after gene therapy for RPE65-LCA.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/25537204","citation_count":34,"is_preprint":false},{"pmid":"18722466","id":"PMC_18722466","title":"Impact of retinal disease-associated RPE65 mutations on retinoid isomerization.","date":"2008","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18722466","citation_count":34,"is_preprint":false},{"pmid":"23407971","id":"PMC_23407971","title":"Fatty acid transport protein 4 (FATP4) prevents light-induced degeneration of cone and rod photoreceptors by inhibiting RPE65 isomerase.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23407971","citation_count":34,"is_preprint":false},{"pmid":"16754667","id":"PMC_16754667","title":"Two point mutations of RPE65 from patients with retinal dystrophies decrease the stability of RPE65 protein and abolish its isomerohydrolase activity.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16754667","citation_count":34,"is_preprint":false},{"pmid":"31572124","id":"PMC_31572124","title":"Generation and Characterization of Induced Pluripotent Stem Cells and Retinal Organoids From a Leber's Congenital Amaurosis Patient With Novel RPE65 Mutations.","date":"2019","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31572124","citation_count":33,"is_preprint":false},{"pmid":"24028205","id":"PMC_24028205","title":"Successful gene therapy in older Rpe65-deficient dogs following subretinal injection of an adeno-associated vector expressing RPE65.","date":"2013","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/24028205","citation_count":33,"is_preprint":false},{"pmid":"29947567","id":"PMC_29947567","title":"Two-year progression analysis of RPE65 autosomal dominant retinitis pigmentosa.","date":"2018","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29947567","citation_count":32,"is_preprint":false},{"pmid":"34088339","id":"PMC_34088339","title":"RPE65-associated inherited retinal diseases: consensus recommendations for eligibility to gene therapy.","date":"2021","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/34088339","citation_count":31,"is_preprint":false},{"pmid":"34281261","id":"PMC_34281261","title":"Inherited Retinal Diseases Due to RPE65 Variants: From Genetic Diagnostic Management to Therapy.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34281261","citation_count":31,"is_preprint":false},{"pmid":"17960108","id":"PMC_17960108","title":"Electroretinographic analyses of Rpe65-mutant rd12 mice: developing an in vivo bioassay for human gene therapy trials of Leber congenital amaurosis.","date":"2007","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/17960108","citation_count":30,"is_preprint":false},{"pmid":"37660736","id":"PMC_37660736","title":"Classification and Growth Rate of Chorioretinal Atrophy after Voretigene Neparvovec-Rzyl for RPE65-Mediated Retinal Degeneration.","date":"2023","source":"Ophthalmology. Retina","url":"https://pubmed.ncbi.nlm.nih.gov/37660736","citation_count":29,"is_preprint":false},{"pmid":"16379027","id":"PMC_16379027","title":"RPE65 surface epitopes, protein interactions, and expression in rod- and cone-dominant species.","date":"2005","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/16379027","citation_count":28,"is_preprint":false},{"pmid":"10386590","id":"PMC_10386590","title":"Identification of RPE65 in transformed kidney cells.","date":"1999","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10386590","citation_count":28,"is_preprint":false},{"pmid":"28041994","id":"PMC_28041994","title":"A Dominant Mutation in Rpe65, D477G, Delays Dark Adaptation and Disturbs the Visual Cycle in the Mutant Knock-In Mice.","date":"2016","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/28041994","citation_count":28,"is_preprint":false},{"pmid":"32535767","id":"PMC_32535767","title":"Voretigene Neparvovec: A Review in RPE65 Mutation-Associated Inherited Retinal Dystrophy.","date":"2020","source":"Molecular diagnosis & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32535767","citation_count":27,"is_preprint":false},{"pmid":"22509104","id":"PMC_22509104","title":"Novel RPE65 mutations associated with Leber congenital amaurosis in Chinese patients.","date":"2012","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/22509104","citation_count":26,"is_preprint":false},{"pmid":"12906125","id":"PMC_12906125","title":"Gene transfer in the RPE65 null mutation dog: relationship between construct volume, visual behavior and electroretinographic (ERG) results.","date":"2003","source":"Documenta ophthalmologica. Advances in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/12906125","citation_count":25,"is_preprint":false},{"pmid":"30628748","id":"PMC_30628748","title":"Aberrant RNA splicing is the major pathogenic effect in a knock-in mouse model of the dominantly inherited c.1430A>G human RPE65 mutation.","date":"2019","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/30628748","citation_count":25,"is_preprint":false},{"pmid":"35395806","id":"PMC_35395806","title":"Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa.","date":"2022","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35395806","citation_count":22,"is_preprint":false},{"pmid":"12387788","id":"PMC_12387788","title":"Light damage susceptibility and RPE65 in rats.","date":"2002","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/12387788","citation_count":22,"is_preprint":false},{"pmid":"11062306","id":"PMC_11062306","title":"A homozygous deletion in RPE65 in a small Sardinian family with autosomal recessive retinal dystrophy.","date":"2000","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/11062306","citation_count":22,"is_preprint":false},{"pmid":"31273949","id":"PMC_31273949","title":"RPE65 mutation frequency and phenotypic variation according to exome sequencing in a tertiary centre for genetic eye diseases in China.","date":"2019","source":"Acta ophthalmologica","url":"https://pubmed.ncbi.nlm.nih.gov/31273949","citation_count":21,"is_preprint":false},{"pmid":"15825812","id":"PMC_15825812","title":"Function of the protein RPE65 in the visual cycle.","date":"2005","source":"Nutrition reviews","url":"https://pubmed.ncbi.nlm.nih.gov/15825812","citation_count":21,"is_preprint":false},{"pmid":"32879773","id":"PMC_32879773","title":"Cost Effectiveness of Voretigene Neparvovec for RPE65-Mediated Inherited Retinal Degeneration in Germany.","date":"2020","source":"Translational vision science & technology","url":"https://pubmed.ncbi.nlm.nih.gov/32879773","citation_count":21,"is_preprint":false},{"pmid":"34492281","id":"PMC_34492281","title":"RPE65-related retinal dystrophy: Mutational and phenotypic spectrum in 45 affected patients.","date":"2021","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/34492281","citation_count":20,"is_preprint":false},{"pmid":"30242264","id":"PMC_30242264","title":"Examining the Role of Cone-expressed RPE65 in Mouse Cone Function.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30242264","citation_count":20,"is_preprint":false},{"pmid":"30914787","id":"PMC_30914787","title":"The dual roles of RPE65 S-palmitoylation in membrane association and visual cycle function.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30914787","citation_count":20,"is_preprint":false},{"pmid":"15009723","id":"PMC_15009723","title":"RPE65 of retinal pigment epithelium, a putative receptor molecule for plasma retinol-binding protein, is expressed in human keratinocytes.","date":"2004","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/15009723","citation_count":20,"is_preprint":false},{"pmid":"35129589","id":"PMC_35129589","title":"RPE65-Associated Retinopathies in the Italian Population: A Longitudinal Natural History Study.","date":"2022","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/35129589","citation_count":19,"is_preprint":false},{"pmid":"29684583","id":"PMC_29684583","title":"A novel RPE65 inhibitor CU239 suppresses visual cycle and prevents retinal degeneration.","date":"2018","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/29684583","citation_count":19,"is_preprint":false},{"pmid":"20510285","id":"PMC_20510285","title":"Cleavage of the retinal pigment epithelium-specific protein RPE65 under oxidative stress.","date":"2010","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/20510285","citation_count":19,"is_preprint":false},{"pmid":"26684444","id":"PMC_26684444","title":"Investor Outlook: Significance of the Positive LCA2 Gene Therapy Phase III Results.","date":"2015","source":"Human gene therapy. Clinical development","url":"https://pubmed.ncbi.nlm.nih.gov/26684444","citation_count":18,"is_preprint":false},{"pmid":"28754419","id":"PMC_28754419","title":"Evaluation of tolerance to lentiviral LV-RPE65 gene therapy vector after subretinal delivery in non-human primates.","date":"2017","source":"Translational research : the journal of laboratory and clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28754419","citation_count":18,"is_preprint":false},{"pmid":"31878136","id":"PMC_31878136","title":"Pathogenicity Reclasssification of RPE65 Missense Variants Related to Leber Congenital Amaurosis and Early-Onset Retinal Dystrophy.","date":"2019","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/31878136","citation_count":18,"is_preprint":false},{"pmid":"21465477","id":"PMC_21465477","title":"Vitamin A metabolism in benign and malignant melanocytic skin cells: importance of lecithin/retinol acyltransferase and RPE65.","date":"2012","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21465477","citation_count":18,"is_preprint":false},{"pmid":"31580392","id":"PMC_31580392","title":"Utility of In Vitro Mutagenesis of RPE65 Protein for Verification of Mutational Pathogenicity Before Gene Therapy.","date":"2019","source":"JAMA ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/31580392","citation_count":18,"is_preprint":false},{"pmid":"21299439","id":"PMC_21299439","title":"Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis.","date":"2011","source":"Expert opinion on biological therapy","url":"https://pubmed.ncbi.nlm.nih.gov/21299439","citation_count":17,"is_preprint":false},{"pmid":"24644049","id":"PMC_24644049","title":"The Rpe65 rd12 allele exerts a semidominant negative effect on vision in mice.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/24644049","citation_count":16,"is_preprint":false},{"pmid":"26390089","id":"PMC_26390089","title":"Investor Outlook: Focus on Upcoming LCA2 Gene Therapy Phase III Results.","date":"2015","source":"Human gene therapy. Clinical development","url":"https://pubmed.ncbi.nlm.nih.gov/26390089","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52831,"output_tokens":7946,"usd":0.138842,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17550,"output_tokens":4524,"usd":0.100425,"stage2_stop_reason":"end_turn"},"total_usd":0.239267,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"Rpe65-deficient mice lack rhodopsin (but retain opsin apoprotein), have abolished rod ERG responses, accumulate all-trans-retinyl esters in the RPE, and lack 11-cis-retinyl esters, establishing that RPE65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle.\",\n      \"method\": \"Rpe65 knockout mouse model; electroretinography; retinoid biochemical analysis by HPLC; immunohistochemistry\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genetic knockout with multiple orthogonal biochemical and functional readouts; foundational paper replicated by subsequent studies\",\n      \"pmids\": [\"9843205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Recombinant RPE65, when expressed in QBI-293A and COS-1 cells, catalyzes the conversion of all-trans-retinyl ester to 11-cis-retinol (isomerohydrolase activity) at a rate of ~2.9 pmol/min per mg; activity requires co-expression of lecithin retinol acyltransferase (LRAT) to provide substrate, establishing RPE65 as the visual cycle isomerohydrolase.\",\n      \"method\": \"Cell-based enzymatic assay (recombinant expression in QBI-293A and COS-1 cells); HPLC retinoid analysis; dose-response correlation with RPE65 expression levels\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro enzymatic reconstitution with substrate requirement defined; independently replicated in same year by Jin et al. (Cell)\",\n      \"pmids\": [\"16116091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"An unbiased cDNA expression screen identified Rpe65 as the retinoid isomerase converting all-trans-retinyl ester to 11-cis-retinol; Leber-associated missense mutations C330Y and Y368H abolished isomerase activity, confirming catalytic identity.\",\n      \"method\": \"Unbiased cDNA expression screen; catalytic activity assay in mammalian and insect cells; site-directed mutagenesis of disease-associated residues\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — unbiased functional screen plus mutagenesis validation; independent replication of isomerohydrolase identity\",\n      \"pmids\": [\"16096063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"RPE65 was molecularly cloned from bovine RPE; the 533-amino-acid protein lacks transmembrane segments, is RPE-specific by Northern blot, and the microsomal membrane-associated form has a higher apparent molecular mass than the soluble form, suggesting post-translational modification; cultured RPE cells contain RPE65 mRNA but no immunodetectable protein, indicating post-transcriptional regulation.\",\n      \"method\": \"cDNA library screening; RACE; heterologous expression in E. coli; Western blot; Northern blot; peptide microsequencing\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — original cloning paper with biochemical characterization; multiple orthogonal methods; foundational\",\n      \"pmids\": [\"8340400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"RPE65 exists in two forms in bovine RPE: a cytosolic form with mass close to calculated (~61 kDa) and a microsomal membrane-associated form with higher mass (~62 kDa), indicating the membrane-associated form carries post-translational modifications; recombinant human RPE65 expressed in Sf9 cells likewise shows membrane-associated and non-membrane forms with differing masses.\",\n      \"method\": \"Baculovirus/Sf9 expression; affinity chromatography purification; MALDI mass spectrometry; subcellular fractionation; Western blot; immunocytochemistry\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mass spectrometry plus fractionation in single lab; establishes post-translational modification on membrane form\",\n      \"pmids\": [\"11381042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"RPE65 lacks transmembrane domains yet associates with RPE microsomal membranes through hydrophobic/phospholipid interactions; RPE65 co-sediments with phosphatidylcholine and other phospholipid liposomes in a Ca2+-independent manner and binds PC-IAM matrix, demonstrating peripheral membrane association via phospholipid binding.\",\n      \"method\": \"Phospholipid liposome co-sedimentation assay; IAM chromatography; resonance energy transfer; spectrophotometric aggregation assay\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical binding assays in single lab; establishes peripheral membrane association mechanism\",\n      \"pmids\": [\"9328280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Hydrophobic interactions are the dominant forces promoting RPE65 association with native RPE microsomal membranes; phospholipid membrane structural integrity is critical for RPE65 isomerization activity (phospholipase A2 treatment inhibits 11-cis-retinol production in correlation with lipid hydrolysis kinetics); RPE65 operates in a multiprotein complex with retinol dehydrogenase 5 (RDH5) and retinal G protein-coupled receptor (RGR) in RPE microsomes.\",\n      \"method\": \"Membrane extraction and phase separation; phospholipase treatment with isomerase activity assay; co-immunoprecipitation from RPE microsomes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods in single lab; establishes membrane dependence and protein complex\",\n      \"pmids\": [\"20100834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Disease-associated RPE65 mutations R91W and Y368H both abolish isomerohydrolase activity in vitro and in vivo (subretinal injection into Rpe65-/- mice); these mutants show decreased protein stability (half-lives <2 h and <6 h vs. >10 h for WT) and shift from membrane to cytosolic fractions, indicating the mutations disrupt membrane association and reduce stability; palmitoylation is retained in both mutants.\",\n      \"method\": \"In vitro isomerohydrolase assay; subretinal injection rescue experiment in Rpe65-/- mice; protein stability/cycloheximide chase; subcellular fractionation; Western blot; palmitoylation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution assay combined with in vivo rescue and protein stability measurement; multiple orthogonal methods\",\n      \"pmids\": [\"16754667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Adenovirus-mediated delivery of RPE65 to Rpe65-/- mice restores isomerohydrolase activity in eyecup homogenates to wild-type levels, restores normal retinoid profile (including 11-cis-retinal), and prevents early cone degeneration, confirming that RPE65 isomerohydrolase activity is required for cone photoreceptor survival.\",\n      \"method\": \"Subretinal adenovirus injection; in vitro isomerohydrolase activity assay; HPLC retinoid profiling; immunohistochemistry; cone counting on flatmounted retina; RT-PCR\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — enzymatic activity restored in vivo with multiple biochemical and histological readouts confirming functional consequence\",\n      \"pmids\": [\"16505056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RPE65 is essential for production of 11-cis-retinal for cone photoreceptors: ablation of RPE65 in Nrl-/- (cone-only) and Rho-/- mice eliminates 11-cis-retinal and causes a ~1000-fold drop in retinal sensitivity, demonstrating RPE65 is indispensable for cone as well as rod visual cycle function.\",\n      \"method\": \"Genetic crosses (Rpe65-/- × Nrl-/- and Rpe65-/- × Rho-/-); electroretinography; HPLC retinoid profiling; Western blot; immunohistochemistry\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — double-knockout epistasis with multiple orthogonal measurements; clearly establishes RPE65 requirement for cone chromophore\",\n      \"pmids\": [\"17251447\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"RPE65 protein is expressed in mammalian cone photoreceptors (mouse, rabbit, cow, Xenopus) but not in rods, as determined by immunohistochemistry on flatmounted and sectioned retinas; double-labeling with PNA confirmed cone identity, and RPE65 knockout confirmed antibody specificity.\",\n      \"method\": \"Immunohistochemistry on flatmounted and sectioned retinas; double-labeling with PNA; Western blot; RPE65 knockout control\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — immunohistochemistry with rigorous knockout control; single lab, two orthogonal detection methods\",\n      \"pmids\": [\"11980880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"RPE65 mRNA is expressed in salamander single cone cells (but not rods), as detected by RT-PCR on isolated cells, suggesting RPE65 contributes to the unique retinoid processing pathway in cones.\",\n      \"method\": \"RT-PCR on individually isolated photoreceptor cells; DNA sequencing confirmation\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, RT-PCR only; functional consequence not directly tested\",\n      \"pmids\": [\"9838153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RPE65 is present in human green/red cones but absent from blue cones; in the 661W cone cell line, RPE65 mediates ester hydrolysis for photopigment synthesis in vitro.\",\n      \"method\": \"Immunohistochemistry on human retinal sections; in vitro ester hydrolysis assay in 661W cone cell line\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — immunohistochemistry plus in vitro functional assay; single lab\",\n      \"pmids\": [\"22171060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RPE65 retinoid isomerase activity is ~4-fold higher in central versus peripheral macaque RPE by direct enzymatic assay, and RPE65 concentrates in central retina by immunoblotting; early cone photoreceptor loss in RPE65-LCA patients indicates robust RPE65-based chromophore production is important for foveal cone survival.\",\n      \"method\": \"Retinoid isomerase activity assay on macaque RPE fractions; immunoblotting; immunocytochemistry; in vivo retinal imaging of human patients\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct enzymatic measurement in primate tissue plus human patient imaging; single lab\",\n      \"pmids\": [\"17848510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The hypomorphic RPE65 mutation P25L reduces isomerohydrolase activity to 7.7% of wild-type in transfected 293F cells, and the L22P mutation to 13.5%; this residual activity correlates with a milder clinical phenotype (preserved cone function), establishing a dose-response relationship between RPE65 isomerase activity level and retinal functional outcome.\",\n      \"method\": \"Cell-based isomerase activity assay (293F cells); HPLC retinoid quantification; clinical ERG and psychophysics\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic assay with quantitative activity measurement correlated to clinical phenotype; single lab\",\n      \"pmids\": [\"18599565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The novel RPE65 mutation G244V (near the catalytic center) causes protein instability in cultured cells and abolishes RPE65-dependent isomerase activity; homology modeling using the carotenoid oxygenase ACO structure localizes known inactivating mutations around the catalytic region.\",\n      \"method\": \"Cell-based isomerase assay; EGFP bicistronic expression + cell sorting + immunoblotting; homology modeling\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic assay plus structural modeling; single lab\",\n      \"pmids\": [\"18722466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Three disease-associated RPE65 missense mutations (L22P, T101I, L408P) at non-active sites cause misfolding and aggregation via disulfide bonds; PSMD13 (26S proteasome non-ATPase regulatory subunit 13) interacts with and mediates rapid ubiquitination/proteasome-dependent degradation of misfolded (but not properly folded) mutant RPE65 proteins; low temperature, sodium 4-phenylbutyrate, and glycerol can rescue catalytic activity of non-active-site mutants but not active-site mutants.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitination assay; proteasome inhibitor experiments; isomerase activity assay; low-temperature rescue assay; chemical chaperone treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (Co-IP, ubiquitination, proteasome inhibition, enzymatic assay, rescue); single lab with comprehensive mechanistic dissection\",\n      \"pmids\": [\"24849605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"FATP4 (fatty acid transport protein 4) is a negative regulator of RPE65 isomerase activity; lignoceroyl (C24:0)-CoA inhibits 11-cis-retinol synthesis whereas palmitoyl (C16:0)-CoA promotes it; FATP4-deficient RPE shows higher isomerase activity, faster 11-cis-retinaldehyde regeneration, and faster rod light sensitivity recovery; FATP4 competes with RPE65 for its substrate all-trans-retinyl ester.\",\n      \"method\": \"Unbiased bovine RPE cDNA expression screen; FATP4 knockout mice; isomerase activity assay; ERG recovery kinetics; substrate competition assay\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — unbiased screen plus knockout model plus substrate competition assay; multiple orthogonal methods\",\n      \"pmids\": [\"23407971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RPE65 undergoes S-palmitoylation (~25% of total protein) at residues C112 and C146; inhibition of palmitoylation abolishes membrane association; palmitoylation-deficient C112 mutants show impaired membrane association; LRAT dynamically regulates RPE65 palmitoylation level (decreased in the presence of all-trans-retinol, the LRAT substrate).\",\n      \"method\": \"Palmitoylation assay (acyl-RAC); 2-bromopalmitate and 2-fluoropalmitate inhibition; site-directed mutagenesis; membrane fractionation; LRAT co-expression experiments\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct palmitoylation assay with site-mapping mutagenesis, chemical inhibition, and functional (membrane association) readout; multiple orthogonal methods\",\n      \"pmids\": [\"30914787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The dominant D477G RPE65 mutation generates an aggregation-prone surface; knock-in mice show ubiquitinated and reduced RPE65, retinyl ester accumulation, delayed rhodopsin regeneration kinetics, and diminished ERG responses; a cell line expressing D477G shows normal localization and isomerase activity, suggesting a toxic gain-of-function through abnormal complex formation rather than simple loss-of-function.\",\n      \"method\": \"D477G knock-in mouse model; immunoblot for ubiquitination; HPLC retinoid analysis; ERG; cell line isomerase activity assay; structural analysis of RPE65 chimera and crystal packing\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — knock-in mouse with multiple biochemical and functional readouts plus structural analysis; multiple orthogonal methods\",\n      \"pmids\": [\"29659842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The D477G dominant mutation acts as a dominant-negative: heterozygous knock-in mice show slower kinetics of 11-cis-retinal regeneration after light exposure and delayed dark adaptation (lower A-wave recovery after photobleaching) compared with both wild-type and RPE65 heterozygous knockout mice, despite comparable steady-state 11-cis-retinal levels.\",\n      \"method\": \"D477G knock-in mouse; ERG photobleach-recovery kinetics; HPLC retinoid analysis\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo knock-in model with ERG and HPLC; single lab; complements Choi et al. 2018\",\n      \"pmids\": [\"28041994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The human RPE65 c.1430A>G (D477G) mutation generates an ectopic splice site causing aberrant splicing of RPE65 mRNA, disrupting protein expression; this splicing defect was confirmed for the human mutant in an in vitro Exontrap assay; homozygous knock-in mice show light-stress-induced retinal degeneration.\",\n      \"method\": \"CRISPR/Cas9 knock-in mouse; Exontrap in vitro splicing assay; ERG; retinal histology; mRNA analysis\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro splicing assay plus knock-in mouse model; single lab; two orthogonal methods\",\n      \"pmids\": [\"30628748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"RPE65 cleavage occurs under oxidative stress: H2O2 exposure of RPE cells generates a novel 45 kDa truncated fragment (RPE45) via a caspase-mediated, ubiquitination-dependent mechanism; the same cleavage occurs in vivo upon light exposure in mice.\",\n      \"method\": \"Western blot; recombinant caspase cleavage assay; mass spectrometry; in vivo light-exposure experiment\",\n      \"journal\": \"International journal of biological macromolecules\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, limited mechanistic detail in abstract; caspase cleavage shown in vitro but ubiquitination-dependence claim not fully described\",\n      \"pmids\": [\"20510285\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The Rpe65 L450M/L450 sequence variant acts as a genetic modifier of retinal degeneration in a transgenic RP mouse model: mice with the Rpe65(450Met) variant retain more rhodopsin and show reduced retinal degeneration compared to mice with the Rpe65(450Leu) variant; phototransduction (not c-Fos) pathway mediates this light-driven degeneration.\",\n      \"method\": \"Transgenic mouse crosses with different Rpe65 variants; ERG; rhodopsin quantification; genetic epistasis (c-Fos KO and phototransduction mutant crosses)\",\n      \"journal\": \"The European journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in vivo with biochemical rhodopsin measurement; single lab\",\n      \"pmids\": [\"16519667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In vivo, the initial rate of 11-cis-retinal synthesis is a Michaelis function of RPE65 quantity (Vmax ~18 pmol/min per eye, Km ~1.7 pmol); at sub-Km RPE65 levels, each RPE65 molecule supports ~10 molecules of 11-cis-retinal per minute regardless of the L450/M450 variant, establishing RPE65 as a quantitative rate-limiting factor for rhodopsin regeneration.\",\n      \"method\": \"Quantitative ELISA for RPE65 per eye; in vivo rhodopsin regeneration kinetics measured by ERG after bleach in five genotypes; Michaelis-Menten kinetic fitting\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative in vivo kinetic analysis across five genotypes in single lab; establishes catalytic rate limit\",\n      \"pmids\": [\"16026160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A novel non-retinoid small molecule inhibitor CU239 selectively inhibits RPE65 isomerase activity (IC50 ~6 μM) via competition with its all-trans-retinyl ester substrate; systemic injection in mice delays chromophore regeneration and partially protects the retina from high-intensity light damage.\",\n      \"method\": \"In vitro isomerase activity assay; competitive inhibition kinetics; in vivo retinoid analysis (HPLC); ERG light-damage model in mice\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular basis of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro competitive inhibition plus in vivo validation; single lab; two orthogonal methods\",\n      \"pmids\": [\"29684583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Nonsense mutation in exon 3 of Rpe65 in the rd12 mouse causes absence of RPE65 protein, no 11-cis-retinal, no rhodopsin, and retinyl ester accumulation in the RPE; the rd12 mutation maps to mouse chromosome 3 near the Rpe65 locus.\",\n      \"method\": \"Genetic linkage analysis; direct sequencing; immunohistochemistry; ERG; biochemical retinoid analysis\",\n      \"journal\": \"Molecular vision\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic mapping plus multiple biochemical confirmations; naturally occurring model corroborating human disease mechanism\",\n      \"pmids\": [\"15765048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Eight RPE65 missense variants predicted to be disease-causing by an EPP algorithm all showed isomerase activity <6% of wild-type in a cell-culture assay; three variants predicted non-pathogenic showed activities of 68%, 127%, and 110% of wild-type; complete concordance between EPP prediction and functional assay established that most RPE65 disease mutations cause loss of isomerase function.\",\n      \"method\": \"Cell-based isomerase activity assay; site-directed mutagenesis of 11 RPE65 variants; EPP algorithm\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic in vitro functional testing of 11 variants; single lab; comprehensive variant series\",\n      \"pmids\": [\"19431183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The rd12 allele does not complement the Rpe65 knockout allele (complementation test), confirming the rd12 lesion is in Rpe65; the rd12 mutant mRNA is correctly spliced and exported to cytoplasm but is enriched on ribosome-free mRNPs rather than actively translating polyribosomes, indicating translational suppression as the mechanism of absent protein; the rd12 allele exerts a semidominant negative effect on visual function.\",\n      \"method\": \"Complementation cross; sucrose gradient polysome fractionation; RNA FISH; qRT-PCR; ERG; optokinetic tracking; immunoblot\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — polysome fractionation plus complementation test plus multiple functional readouts; single lab; multiple orthogonal methods\",\n      \"pmids\": [\"24644049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In zebrafish (cone-dominated retina), RPE65 knockdown reduces 11-cis-retinal levels and alters rod outer segment morphology, but cone vision remains functional; all-trans retinylamine (rod visual cycle inhibitor) does not have additive effects in RPE65-deficient larvae, providing in vivo evidence for an RPE65-independent pathway for cone 11-cis-retinal regeneration.\",\n      \"method\": \"Morpholino-mediated gene knockdown in zebrafish; behavioral vision testing; HPLC retinoid profiling; retinylamine pharmacological inhibition\",\n      \"journal\": \"The European journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockdown plus pharmacological epistasis in vivo; single lab; two orthogonal approaches\",\n      \"pmids\": [\"17868371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"A 4-nucleotide (AAGA) deletion in canine RPE65 (nucleotides 487-490) causing a frameshift and premature stop codon is homozygous in RPE65-mutant Briard dogs with congenital stationary night blindness and retinal dystrophy; the mutation causes retinal dysfunction and RPE lipid vacuole accumulation, demonstrating that RPE65 loss of function disrupts the visual cycle and retinal architecture.\",\n      \"method\": \"RT-PCR and cDNA cloning; direct sequencing; ERG; fundus and morphological examination; haplotype analysis\",\n      \"journal\": \"Molecular vision\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and biochemical characterization of naturally occurring animal model; corroborates knockout mouse mechanism\",\n      \"pmids\": [\"9808841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Cone-expressed RPE65 in mouse cones does not detectably contribute to cone function or morphology in transgenic mice expressing human RPE65 specifically in cones on an RPE65-deficient background; only a slight delay in dark adaptation was observed, possibly due to retinoid buffering.\",\n      \"method\": \"Transgenic mice (cone-specific human RPE65 expression in RPE65-deficient background); ERG dark adaptation; single-cell electrophysiology; morphological analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function transgenic model with multiple functional readouts; single lab; negative result for cone-specific RPE65 function in mouse\",\n      \"pmids\": [\"30242264\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RPE65 is an isomerohydrolase enzyme in the retinal pigment epithelium that catalyzes the conversion of all-trans-retinyl esters (provided via LRAT activity) to 11-cis-retinol, the rate-limiting step in visual chromophore regeneration; it associates with ER membranes through hydrophobic and S-palmitoylation (at C112/C146, ~25% of protein) interactions, operates in a multiprotein complex with RDH5 and RGR, is negatively regulated by FATP4/ELOVL1 via competition for substrate, is targeted for proteasomal degradation when misfolded (via PSMD13), and is essential for both rod and cone photoreceptor function; most disease-causing missense mutations abolish isomerase activity or destabilize the protein, while the dominant D477G mutation delays chromophore regeneration through a toxic gain-of-function or dominant-negative mechanism involving abnormal complex formation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RPE65 is the retinal pigment epithelium-specific retinoid isomerohydrolase that performs the rate-limiting step of the visual cycle, converting all-trans-retinyl esters into 11-cis-retinol for regeneration of the visual chromophore [#1, #2, #24]. Genetic ablation in mice abolishes 11-cis-retinoid production and rhodopsin, accumulates all-trans-retinyl esters in the RPE, and eliminates rod ERG responses, establishing RPE65 as indispensable for chromophore supply [#0]; epistasis in cone-only and rod-null backgrounds shows it is equally required for cone vision, with foveal cones being especially dependent on robust RPE65 activity [#9, #13]. Catalysis requires LRAT to generate the all-trans-retinyl ester substrate, and RPE65 functions within an RPE microsomal multiprotein complex together with RDH5 and RGR [#1, #6]. Although it lacks transmembrane segments, RPE65 associates peripherally with ER/microsomal membranes through hydrophobic and phospholipid interactions and through S-palmitoylation at C112 and C146, with membrane integrity being essential for isomerase activity [#5, #6, #18]. RPE65 activity is quantitatively rate-limiting and tunable: it is negatively regulated by FATP4 through competition for the retinyl ester substrate, with very-long-chain acyl-CoAs inhibiting and palmitoyl-CoA promoting activity [#17, #24]. RPE65 loss-of-function and instability cause inherited retinal dystrophy: most disease-associated missense mutations abolish isomerase activity or destabilize the protein, and non-active-site misfolding mutants are cleared by PSMD13-mediated ubiquitin-proteasome degradation, whereas the dominant D477G mutation delays chromophore regeneration through a toxic/dominant-negative mechanism involving abnormal complex formation [#7, #16, #19, #27].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established RPE65 as an RPE-specific protein and raised the question of how a soluble-looking protein associates with membranes, setting up the membrane-association and post-translational regulation problems.\",\n      \"evidence\": \"cDNA cloning from bovine RPE, Northern/Western blot, peptide microsequencing\",\n      \"pmids\": [\"8340400\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not assign a catalytic function\", \"Nature of the higher-mass membrane modification undefined\", \"Mechanism of post-transcriptional regulation in cultured RPE not identified\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined RPE65's physiological role by showing its loss blocks 11-cis-retinoid production and rhodopsin formation, identifying it as a required node in the retinal visual cycle.\",\n      \"evidence\": \"Rpe65 knockout mice with ERG, HPLC retinoid analysis, immunohistochemistry; corroborated by canine frameshift model\",\n      \"pmids\": [\"9843205\", \"9808841\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish the biochemical reaction RPE65 catalyzes\", \"Direct enzyme activity not demonstrated\", \"Role in cones not yet tested\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Showed RPE65 is a peripheral membrane protein associating with microsomes via phospholipid/hydrophobic interactions, answering how a protein lacking transmembrane domains localizes to membranes.\",\n      \"evidence\": \"Liposome co-sedimentation, IAM chromatography, resonance energy transfer\",\n      \"pmids\": [\"9328280\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific residues/modifications mediating association not mapped\", \"Single-lab biochemistry\", \"Functional consequence of membrane association untested here\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Resolved RPE65's molecular activity by directly demonstrating isomerohydrolase catalysis of all-trans-retinyl ester to 11-cis-retinol, and showed it depends on LRAT for substrate and is quantitatively rate-limiting in vivo.\",\n      \"evidence\": \"Recombinant expression enzymatic assays in mammalian/insect cells with HPLC, unbiased cDNA screen, mutagenesis of LCA residues, in vivo Michaelis-Menten kinetics; rd12 nonsense model\",\n      \"pmids\": [\"16116091\", \"16096063\", \"16026160\", \"15765048\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Catalytic mechanism/cofactor requirements not fully defined\", \"Structure not solved\", \"Relationship to membrane association mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrated RPE65 is required for the cone as well as rod visual cycle, addressing whether cones use an RPE65-independent chromophore source.\",\n      \"evidence\": \"Rpe65 ablation in Nrl-/- and Rho-/- mice with ERG and HPLC; gene-delivery rescue preventing cone degeneration; cone expression and central RPE enrichment data\",\n      \"pmids\": [\"17251447\", \"16505056\", \"11980880\", \"22171060\", \"17848510\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether cone-intrinsic RPE65 contributes vs RPE-derived chromophore not resolved\", \"Cone-specific alternative pathway in some species (zebrafish) unexplained\", \"Quantitative cone vs rod chromophore demand undefined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Tested whether RPE65 expressed within cones is functionally relevant, refining where chromophore-regenerating activity matters.\",\n      \"evidence\": \"Cone-specific human RPE65 transgenic mice on RPE65-deficient background; ERG, single-cell electrophysiology; zebrafish knockdown with retinylamine epistasis\",\n      \"pmids\": [\"30242264\", \"17868371\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Negative result in mouse may not generalize across species\", \"Identity of the RPE65-independent cone pathway unknown\", \"Buffering vs catalytic role of cone RPE65 unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Connected disease mutations to mechanism by showing inactivating mutations abolish isomerase activity and destabilize protein while shifting it off membranes, defining loss-of-function as the dominant disease route.\",\n      \"evidence\": \"In vitro isomerase assays, subretinal rescue in Rpe65-/- mice, cycloheximide-chase stability, fractionation; systematic functional testing of variant series; homology modeling\",\n      \"pmids\": [\"16754667\", \"19431183\", \"18599565\", \"18722466\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Per-residue catalytic contributions not fully mapped without a crystal structure\", \"Relationship between stability loss and membrane displacement mechanistically incomplete\", \"Residual-activity thresholds for phenotype only correlative\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified the quality-control pathway disposing of misfolded RPE65, showing PSMD13 mediates ubiquitin-proteasome degradation of misfolding mutants and that chemical chaperones rescue non-active-site but not active-site mutants.\",\n      \"evidence\": \"Co-IP, ubiquitination assay, proteasome inhibition, isomerase activity, low-temperature and 4-PBA/glycerol rescue; rd12 translational-suppression analysis\",\n      \"pmids\": [\"24849605\", \"24644049\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PSMD13 acts via canonical 26S targeting or a dedicated recognition step unclear\", \"In vivo relevance of this pathway not tested\", \"E3 ligase for RPE65 not identified\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Revealed metabolic regulation of RPE65 by showing FATP4 negatively modulates isomerase activity through substrate competition and acyl-CoA chain-length effects, linking chromophore regeneration speed to lipid metabolism.\",\n      \"evidence\": \"Unbiased bovine RPE cDNA screen, FATP4 knockout mice, isomerase and ERG recovery kinetics, substrate competition assays\",\n      \"pmids\": [\"23407971\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological conditions that engage FATP4 regulation undefined\", \"Whether ELOVL1 or other lipid enzymes participate not tested here\", \"Stoichiometry of competition at the membrane unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined S-palmitoylation as a regulated determinant of RPE65 membrane association, mapping modified cysteines and linking palmitoylation dynamics to LRAT substrate availability.\",\n      \"evidence\": \"Acyl-RAC palmitoylation assay, palmitoylation inhibitors, C112/C146 mutagenesis, membrane fractionation, LRAT co-expression\",\n      \"pmids\": [\"30914787\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Palmitoyltransferase responsible not identified\", \"Functional consequence on catalytic rate vs localization not fully separated\", \"In vivo significance of dynamic palmitoylation untested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Mechanistically dissected the dominant D477G mutation, showing it acts through a toxic gain-of-function/dominant-negative route (aggregation-prone surface, abnormal complex formation, delayed regeneration) plus a human splicing defect, distinguishing it from recessive loss-of-function.\",\n      \"evidence\": \"D477G knock-in mice with HPLC/ERG/ubiquitination, cell-line activity assay, structural analysis, heterozygote dominant-negative kinetics, Exontrap splicing assay\",\n      \"pmids\": [\"29659842\", \"28041994\", \"30628748\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of splicing defect vs protein-level toxicity in humans unresolved\", \"Composition of the abnormal complex not defined\", \"Whether the same mechanism operates in human RPE not directly shown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Established pharmacological tractability of the substrate-binding site by developing a competitive non-retinoid inhibitor that slows chromophore regeneration and protects against light damage.\",\n      \"evidence\": \"In vitro competitive inhibition kinetics (CU239), in vivo HPLC and ERG light-damage model in mice\",\n      \"pmids\": [\"29684583\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Binding mode not structurally resolved\", \"Therapeutic window and selectivity in humans untested\", \"Long-term consequences of chronic inhibition unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How RPE65, LRAT, RDH5, RGR and lipid regulators are spatially organized into a functional membrane-bound visual-cycle machine, and the high-resolution catalytic mechanism of isomerization, remain incompletely defined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No experimentally determined high-resolution structure of human RPE65 in the timeline\", \"Architecture and stoichiometry of the RDH5/RGR complex undefined\", \"Identity of palmitoyltransferase and ubiquitin ligase acting on RPE65 unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016853\", \"supporting_discovery_ids\": [1, 2, 8, 14, 27]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [1, 12]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [5, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [4, 5, 6]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4, 7]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [5, 18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0009579\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [0, 8, 9]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 17]}\n    ],\n    \"complexes\": [\"RPE65-RDH5-RGR RPE microsomal isomerization complex\"],\n    \"partners\": [\"LRAT\", \"RDH5\", \"RGR\", \"FATP4\", \"PSMD13\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":6,"faith_pct":83.33333333333333}}